PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16963021-9	2006	Isorhamnetin pretreatment inhibited the ox-LDL-induced downregulation of eNOS, upregulation of lectin-like ox-LDL receptor-1, phosphorylation of the p38MAPK and translocation of NF-kappaB.	3-methylquercetin	0-12	nuclear factor kappa B subunit 1	Homo sapiens	178-187	
22489690-8	2012	Expression of phospho-Akt and p53 showed no detectable change during the first 48 h. Pretreatment with the NF-kappaB inhibitor MG132 before exposure to isorhamnetin blocked the nuclear accumulation of p50 and p65, thereby inhibiting cell proliferation.	3-methylquercetin	152-164	nuclear factor kappa B subunit 1	Homo sapiens	201-204	
33569004-0	2020	Isorhamnetin Enhances the Radiosensitivity of A549 Cells Through Interleukin-13 and the NF-kappaB Signaling Pathway.	3-methylquercetin	0-12	nuclear factor kappa B subunit 1	Homo sapiens	88-97	
33569004-8	2020	We also found that the IR-induced NF-kappaB signaling activation was inhibited by ISO pretreatment, and it was abrogated in IL-13 silenced cells.	3-methylquercetin	82-85	nuclear factor kappa B subunit 1	Homo sapiens	34-43	
33569004-9	2020	We speculated that ISO may confer radiosensitivity on A549 cells via increasing the expression of IL-13 and inhibiting the activation of NF-kappaB.	3-methylquercetin	19-22	nuclear factor kappa B subunit 1	Homo sapiens	137-146	
33569004-10	2020	To our knowledge, this is the first report demonstrating the effects of ISO treatment on the responsiveness of lung cancer cells to irradiation through IL-13 and the NF-kappaB signaling pathway.	3-methylquercetin	72-75	nuclear factor kappa B subunit 1	Homo sapiens	166-175	
32865318-0	2021	Isorhamnetin attenuates TNF-alpha-induced inflammation, proliferation, and migration in human bronchial epithelial cells via MAPK and NF-kappaB pathways.	3-methylquercetin	0-12	nuclear factor kappa B subunit 1	Homo sapiens	134-143	
32865318-14	2021	Treatment with isorhamnetin inhibited the phosphorylation of mitogen-activated protein kinase (MAPK) and NF-kappaB pathways induced by TNF-alpha.	3-methylquercetin	15-27	nuclear factor kappa B subunit 1	Homo sapiens	105-114	
32865318-15	2021	In summary, isorhamnetin inhibited the inflammation, proliferation, and migration of BEAS-2B cells by regulating the MAPK and NF-kappaB signalling pathways and is a drug candidate for asthma.	3-methylquercetin	12-24	nuclear factor kappa B subunit 1	Homo sapiens	126-135	
26578299-12	2016	Isorhamnetin inhibits FasL-mediated extrinsic apoptosis and neurotrophic factor kappaB (NF-kappaB) nuclear translocation, which can induce the cell DNA damage.	3-methylquercetin	0-12	nuclear factor kappa B subunit 1	Homo sapiens	88-97